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Abstract
A fluorescent sensor of protein kinase activity has been developed and used to characterize the
compartmentalized location of cAMP-dependent protein kinase activity in mitochondria. The sensor
functions via a phosphorylation-induced release of a quencher from a peptide-based substrate,
producing a 150-fold enhancement in fluorescence. The quenching phenomenon transpires via
interaction of the quencher with Arg residues positioned on the peptide substrate. Although the
cAMP-dependent protein kinase is known to be present in mitochondria, the relative amount of
enzyme positioned in the major compartments (outer membrane, intermembrane space, and the
matrix) of the organelle is unclear. The fluorescent sensor developed in this study was used to reveal
the relative matrix:intermembrane space:outer membrane (85:6:9) distribution of PKA in bovine
heart mitochondria.
Protein kinases are a large enzyme family that have been implicated in nearly every cell-based
behavior, from ATP generation to unrestrained growth and division.1 These enzymes are linked
by their ability to catalyze phosphoryl transfer from ATP to the hydroxyl moieties of serine,
threonine, and/or tyrosine residues in proteins. A variety of factors limit protein kinase-
catalyzed phosphorylation to intended protein targets: (a) the ability to phosphorylate serine/
threonine or tyrosine, but only rarely both aliphatic and aromatic residues, (b) differential
expression as a function of cell type, (c) recognition of specific amino acid sequences
encompassing the hydroxyl phosphoryl acceptor moiety, and (d) localization to specific
intracellular sites. The cAMP-dependent protein kinase (PKA) exhibits many of these attributes
as a serine/threonine-specific protein kinase with a special preference for sequences of the
general form Arg-Arg-Xaa-Ser/Thr-Xaa in protein substrates.2 In addition, PKA is anchored
to a variety of intracellular sites via coordination to A-Kinase Anchoring Proteins (AKAPs),
and thus the biological consequences of its action are location-dependent.3 For example,
mitochondrial PKA is implicated in the regulation of apoptosis and ATP synthesis.4 However,
as is true for protein kinases in general, presumed intracellular PKA activity is commonly
assessed in an indirect fashion: either by the mere presence of the enzyme
(immunofluorescence or western blots) or by the effect of small molecule modulators, such as
inhibitors, on the phosphorylation of presumed PKA protein substrates. Unfortunately, these
commonly employed methods don’t furnish a direct measure of kinase activity.
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Fluorescent sensors have been used to directly and continuously assess kinase action.5
However, these either display a limited dynamic range or employ fluorophores with
photophysical properties (short λex/λem6, small ε,7 low Φ) that are incompatible (due to
interference from autofluorescence) with cells, cell lysates, or organelles. With the latter
limitation in mind, we report herein the application of a quenched fluorescence strategy6 to
create a kinase sensor of unprecedented dynamic range. Sensors with a large dynamic range
can be used in relatively small quantities, thereby diminishing the likelihood of interference
with ongoing biochemical processes (i.e. Observer Effect).8 The favorable properties
associated with the sensor have allowed us to assess the relative abundance of PKA in the major
mitochondrial microenvironments (outer membrane, intermembrane space, and matrix).9–13
Results and Discussion
The fluororophores described in this report are coumarin derivatives, which possess
photophysical properties (Table 1) that are readily amenable to biological applications. Three
coumarin-derivatized peptides (1 – 3; Figure 1) of the general form coumarin-Aoc-
GRTGRRFSYP-amide were prepared (where Aoc = aminooctanoic acid). These positively
charged peptides were exposed to forty-seven different negatively charged dyes (Supporting
Information, Table S1) with the expectation that complex formation would result in the
quenching of coumarin fluorescence. In addition, we anticipated that PKA-catalyzed
phosphorylation of coumarin-Aoc-GRTGRRFSYP-amide would promote association of the
phosphorylated peptide with the 14-3-3 domain14, thereby releasing the quenching dye and
restoring fluorescence (Scheme 1). The lead quencher dye for all three peptides proved to be
Acid Green 27 (4) and the observed PKA-catalyzed changes in fluorescence in the presence
of 4 are: peptide 1 (152-fold), peptide 2 (150-fold), and peptide 3 (28-fold) (Table 1 and Figure
2). Given its large dynamic range and relatively high Vmax (Table 1), we decided to employ
peptide 1 in all subsequent studies.
We confirmed that phosphoryl transfer from ATP to the serine hydroxyl moiety of the peptide
sensor is required for the observed fluorescent enhancement by examining analogs of the
peptide substrate 1 and ATP. First, substitution of peptide 1 with by its non-phosphorylatable
Ala-for-Ser counterpart 5 fails to elicit a change in fluorescence (Figure 2D). Second,
substitution of ATP with the corresponding thio-derivative, ATP(γ)S, dramatically reduces the
rate of fluorescence change (Supporting Information, Figure S1). ATP(γ)S is known to serve
as a weak thiophosphoryl donor in protein kinase-catalyzed reactions.15,16
Both 14-3-3 and the fluorescent quencher, Acid Green 27 (4), are required for the large
phosphorylation-induced fluorescence yield. In the absence of 14-3-3 (but with quencher 4
present), no change in fluorescence is observed (Supporting Information, Figure S2).
Furthermore, there exists a direct correlation between the relative amount of 14-3-3 present
and the observed phosphorylation-dependent fluorescent enhancement (Supporting
Information, Figure S2). Surprisingly, in the absence of quencher 4 (but with 14-3-3 present),
there is a 50% decrease in observed fluorescence (Supporting Information, Figure S3). One
possible explanation for the unexpected fluorescent decrease is the likely orientation of the
14-3-3-bound phospho-peptide 1 based on a previously described crystal structure.17 The N-
terminus of the peptide, when complexed with the 14-3-3 domain, is positioned adjacent to
two tryptophan residues (Supporting Information, Figure S4). We,18 as well have others,19
have shown that tryptophan can serve as a fluorescent quencher. 14-3-3 domain-mediated
quenching of phosphocoumarin-peptide fluorescence is intriguing since it suggests that
removal of the tryptophan residues in the 14-3-3 domain could furnish fluorescence fold
changes even larger than those observed in this study.
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We examined the underlying assumption that the negatively charged quencher 4 engages the
positively charged peptide substrate via electrostatic interactions. A small library of Arg-to-
Ala substituted peptide analogs were prepared and KD values were acquired for each of these
with Acid Green 27, using fluorescence quenching as an indicator of complex formation. As
is clear from Table 2, the quenching phenomenon is Arg residue-dependent, with the apparent
KD displaying an approximate two orders of magnitude loss for every Arg replaced by an Ala.
The effect is independent of the site of the Ala-for-Arg substitution (cf. 6 vs. 7 vs. 8), implying
a diffuse electrostatic interaction between the negatively charged dye and the peptide substrate.
Job plot analysis revealed the formation of a 1:1 complex between 1 and 4 (Figure 3).
The large fluorescent dynamic range of the PKA-catalyzed phosphorylation of peptide 1
furnishes a sensitive measure of kinase activity. The catalytic activity of PKA at a concentration
as low as 160 pM can be detected as demonstrated by the plot of initial rate versus PKA
concentration (Figure 4). Figure 4 provides a standard curve for assessing “PKA activity
equivalents” in biological systems.
Although the indispensable nature of the PKA signaling pathway in mitochondrial physiology
is beyond dispute,4 its suborganelle location within the mitochondria (i.e. matrix,
intermembrane space, and/or on the outer membrane oriented toward the cytoplasm; Figure 5)
is enigmatic. Orr and colleagues demonstrated (via electron microscopy) that type II PKA is
primarily associated with the outer membrane of mitochondria in male germ cells.20 Indeed,
a major mitochondrial A-Kinase Anchoring Protein (AKAP121 in mice and AKAP149 in
humans), and its splice variants, position PKA on the cytoplasmic face of the outer membrane.
11 Proteolysis of this AKAP21,22 appears to promote apoptosis by releasing PKA from the
outer membrane, which is known to promote anti-apoptotic behavior23,24. By contrast,
Schwoch et al showed (via electron microscopy) that both types I and II PKA are primarily
associated with the mitochondrial matrix/inner membrane in mitochondria isolated from a wide
variety of organs.12 Matrix localization of PKA has also been observed in neuronal
mitochondria.13 Papa and his colleagues found that PKA is associated with the inner membrane
of bovine heart mitochondria.25 Furthermore, these investigators reported a detailed electron
microscopic analysis of rat heart mitochondria and concluded that more than 90% of all
mitochondrial-bound PKA is present in the inner mitochondrial compartment.10 However, an
additional complication, not described by these studies, is the enzymatic reach of PKA. In
particular, the majority of mitochondrial proteins are nuclear encoded and thus must be
imported from the cytoplasm. Consequently, although a variety of mitochondrial proteins are
phosphorylated in a cAMP-dependent fashion, they may suffer PKA-catalyzed
phosphorylation during import (e.g. at the outer membrane), and thus prior to being embedded
within their final destination (e.g. in the matrix).25 In short, the mitochondrial location of known
PKA substrates is not necessarily a valid indicator of microenvironmental PKA activity.
Finally, the active form of PKA (C subunit), which is released from the inactive holoenzyme
(R2C2) upon exposure to cAMP, can diffuse through membranes.26 Therefore, the suborganelle
location of the holoenzyme (as determined by electron microscopy) does not necessarily
recapitulate the location of the active form of the enzyme. With these factors in mind, we turned
our attention to the suborganelle analysis of cAMP-activated PKA in isolated bovine heart
mitochondria.
Perhaps the most obvious approach for assessing PKA activity as a function of mitochondrial
microenvironment is purification of the enzyme from the outer membrane, the intermembrane
space, and the matrix. However, such a strategy is not practical for both structural and
technological reasons. The holoenzyme resides as an AKAP-bound membrane-associated
species on the outer membrane and likely, in an analogous AKAP-dependent fashion, at the
inner membrane. Unfortunately, even if it were feasible to isolate and purify the outer and inner
membrane components, it would not be clear which direction the enzyme is facing in the intact
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mitochondrion (i.e. an outer membrane-bound species could be oriented outward toward the
cytoplasm or inward toward the intermembrane space). An alternative approach might involve
the cAMP-induced release of the C subunit and its subsequent isolation from the
extramitochondrial, intermembrane space, and matrix regions. However, as demonstrated with
bovine heart mitochondria, the standard technique used to expose the contents of the
intermembrane space (digitonin treatment) results in some disruption of the matrix as well,
leading to contamination of the intermembrane space contents with components from the
matrix.27 Therefore, we resorted to the strategy depicted in Figure 5.
We reasoned that exposure of intact mitochondria to cAMP should activate PKA located on
the outer membrane as well as any PKA present in the intermembrane space (i.e. inner leaflet
of the outer membrane and/or outer leaflet of the inner membrane). The mitochondrial outer
membrane contains a channel forming protein-based complex (porin; also known as the voltage
dependent anion channel) that allows small molecules (<5000 molecular weight) to passively
diffuse between the extramitochondrial environment and the intermembrane space.28 We
expected that, in addition to cAMP, our PKA sensor 1 and quencher 4 should be able to freely
migrate into and out of the intermembrane space and thus report any PKA activity (by contrast,
the inner membrane blocks access to the matrix of externally added cAMP29). This approach
avoids the use of digitonin, and thus should prevent contamination by the unintended release
of matrix contents. In short, cAMP-treated mitochondria should furnish outer membrane and
intermembrane space PKA activity. Furthermore, since trypsin digests only outward-facing
outer membrane mitochondrial proteins,9 we expected that cAMP-exposed trypsin-treated
mitochondria should provide only intermembrane space PKA activity (Figure 5). Finally,
mitochondrial structural integrity is completely disrupted by sonication and thus mitochondria
treated in this fashion should yield, upon cAMP exposure, total mitochondrial PKA activity.
These three activities can then be used to assign relative PKA activity to the three separate
mitochondrial microenvironments.
The purity of mitochondria isolated from bovine heart was assessed via Western blot analysis
using antibodies against proteins that are localized to mitochondrial (cytochrome C) and non-
mitochondrial sites, including the endoplasmic reticulum (calnexin), the plasma membrane
(Na+/K+ ATPase), and the cytosol (GAPDH) (Figure 6A). The results demonstrate that the
mitochondrial preparation is not contaminated with proteins from other membranes or the ER,
and displays only minimal contamination from the cytoplasm. Mitochondrial structural
integrity (intactness) was assessed as previously described30,31 and found to be greater than
90% (data not shown).
Intact mitochondria, upon exposure to cAMP, exhibit an initial rate of PKA activity equivalent
to 29 ± 4 pg PKA/µg mitochondria. By contrast, in the absence of cAMP, phosphorylation
activity is minimal (Supporting Information, Figure S5); demonstrating that sensor 1 is
phosphorylated in a cAMP-dependent fashion. Indeed, previous studies have shown that active
site directed sequences, similar to the sequence employed in sensor 1, are highly selective for
PKA.32–34 Finally, we have found that H-89, a PKA inhibitor, blocks the phosphorylation of
sensor 1 by mitochondrial preparations (Supporting Information, Figure S6). These results are
consistent with the notion that peptide 1 serves as a selective PKA sensor.
As noted above (Figure 5), we expected that the PKA activity associated with intact
mitochondria would be a combination of enzyme present on the outer membrane and enzyme
oriented into the intermembrane space. We addressed this possibility by treating mitochondria
with trypsin, which should selectively hydrolyze the outer membrane proteins exposed to the
external milieu (Figure 6B), but not hydrolyze matrix- or intermembrane space-embedded
proteins. Indeed, an outer membrane marker (TOM 20) is completely digested in trypsin-
treated mitochondria, whereas a matrix marker (Hsp 60) is unperturbed. Previous studies with
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trypsin-exposed mitochondria demonstrated that an intermembrane space marker is protected
against proteolysis as well.9 Subsequent analysis of PKA activity (cAMP exposure) in trypsin-
treated mitochondria revealed a drop in PKA activity from 24 ± 4 pg PKA/µg mitochondria to
10 ± 1 pg PKA/µg mitochondria, implying a 1:1.4 ratio of intermembrane space:outer
membrane (external) PKA. Finally, mitochondria were sonicated to completely disrupt their
structural integrity, thereby exposing all mitochondria-associated PKA, including any matrix-
embedded enzyme. Total mitochondrial PKA activity (cAMP treatment) is equivalent to 165
± 24 pg PKA/µg mitochondria, approximately 5.7 times greater than that observed with intact
mitochondria. These values suggest that the relative distribution of PKA activity in the matrix
(165 ± 24 pg PKA/µg mitochondria − 24 ± 4 pg PKA/µg mitochondria = 141 pg PKA/µg
mitochondria), the intermembrane space (10 ± 1 pg PKA/µg mitochondria), and the outer
membrane (24 ± 4 pg PKA/µg mitochondria − 10 ± 1 pg PKA/µg mitochondria = 14 pg PKA/
µg mitochondria) in bovine heart mitochondria is 85:6:9, respectively. The latter compares
favorably with the electron microscopy work of Papa and colleagues,10 who reported that 90%
of the PKA present in mitochondria is found the matrix and the intermembrane space. However,
our analysis could be complicated by endogenous protein phosphatases if they are present in
different amounts in the three distinct mitochondrial compartments. Consequently, an
analogous series of experiments were conducted in the presence of a phosphatase inhibitor
cocktail. The experimentally determined ratio (79:8:13) of matrix:intermembrane space:outer
membrane PKA activity corresponds to that acquired in the absence of phosphatase inhibitors.
In summary, we have developed a protein kinase sensing system with a robust dynamic range
and used it to characterize the compartmentalized location of PKA activity in mitochondria.
Given the important role of PKA in mediating the dynamics of mitochondrial biochemistry,
the ability to monitor protein kinase activity should prove useful in assessing the mitochondrial




General reagents and solvents were purchased from Fisher or Sigma-Aldrich. Novasyn TGR
Resin, all natural Fmoc-protected amino acids were purchased from EMD Biosciences Inc.
HCTU [1H-benzotriazolium 1-[bis(dimethylamino)methylene]-5-chloro-
hexafluorophosphate (1-),3-oxide] was purchased from Peptides International (Louisville,
KY). Fluorescent dyes (7-(diethylamino)coumarin-3-carboxylic acid, Coumarin 343 [11-
oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylic
acid], and Atto 425-NHS ester were purchased from Sigma-Aldrich. Fmoc-aminooctanoic acid
(Fmoc-Aoc-OH) was purchased from Advanced ChemTech (Louisville, KY). Bovine heart
mitochondria was purchased from MitoSciences and trypsin (sequencing grade) and PKA were
purchased from Promega. The antibodies against the PKA catalytic subunit, Tom 20, and
Hsp60 were purchased from BD Biosciences and the goat anti-mouse secondary antibody was
purchased from Santa Cruz Biotechnology. Total mitochondrial protein was quantified using
the BCA protein assay (Pierce). Immunoblots were performed using Snap i.d. (Millipore), and
visualized using an AlphaInnotech FluorChem FC2 imager. The intactness of the isolated
mitochondria was assessed via a previously described protocol.30,31 PKA murine catalytic
subunit (cat) plasmid and the GST-14-3-3τ plasmid were generous gifts from Dr. Susan Taylor
and Dr. Alistair Aitken, respectively.
Synthesis of fluorophore-labeled PKA substrates
Peptides were synthesized using standard Fmoc solid phase synthesis on a Prelude peptide
synthesizer (Protein Technologies Inc, Tucson, Az). Novasyn TGR resin was swelled for 30
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min in dichloromethane (DCM) before synthesis. Amino acids were then sequentially coupled
using 5.0 equiv. amino acid, 4.9 equiv. HCTU, 20 equiv. diisopropylethylamine (DIPEA) in
N,N-dimethylformamide (DMF) (2 × 5 min) followed by DMF wash (6 × 30 s). The Fmoc-
protecting group was removed using 20% piperidine in DMF (2 × 2.5 min) followed by a DMF
wash (6 × 30 s). The free N-terminal amine was used for subsequent on-resin fluorophore
labeling. Fluorescent dyes diethylcoumarin and Coumarin 343 were coupled to the N-terminal
amine using 5.0 equiv. fluorophore, 4.9 equiv. HCTU, 20 equiv. DIPEA in DMF (1× 60 min).
Atto425-NHS ester was coupled using 1.0 equiv. dye and 20 equiv. DIPEA in DMF (1 × 60
min). The resin was washed (3× DMF, IPA, DCM) and then cleaved and deprotected using a
95:2.5:2.5 mixture of trifluoroacetic acid (TFA), H2O, and triisopropylsilane (TIPS). The
peptides were isolated via filtration, precipitated with ice-cold ether, and centrifuged to isolate
the precipitate. The precipitates were air-dried, dissolved in DMSO, and purified using HPLC
(3% – 40% acetonitrile gradient against water with 0.1% TFA over 40 min). The peak
corresponding to the peptide was collected, freeze dried, and characterized by electrospray
ionization mass spectrometry: 1 Cou-Aoc-GRTGRRFSYP-amide [Exact Mass calculated:
1579.84, found: 1580.84 (M + H)+], 2 Atto425-Aoc-GRTGRRFSYP-amide [Exact Mass
calculated: 1719.98, found: 1720.97 (M+H)+], 3 Cou343-Aoc-GRTGRRFSYP-amide [Exact
Mass calculated: 1603.82, found: 1604.85 (M+H)+], 5 Cou-Aoc-GRTGRRFAYP-amide
[Exact Mass calculated: 1562.8, found: 782.6 (M+2H)2+, 522.2 (M+3H)3+], 6 Cou-Aoc-
GATGRRFSYP-amide [Exact Mass calculated: 1494.69, found: 1495.80 (M+H)+], 7 Cou-
Aoc-GRTGARFSYP-amide [Exact Mass calculated: 1494.69, found: 1495.77 (M+H)+], 8
Cou-Aoc-GRTGRAFSYP-amide [Exact Mass calculated: 1495.69, found: 1495.78 (M+H)+],
9 Cou-Aoc-GATGRAFSYP-amide [Exact Mass calculated: 1409.58, found: 1409.72 (M
+H)+], 10 Cou-Aoc-GATGARFSYP-amide [Exact Mass calculated: 1409.58, found: 1409.73
(M+H)+], 11 Cou-Aoc-GRTGAAFSYP-amide [Exact Mass calculated: 1409.58, found:
1409.72 (M+H)+], and 12 Cou-Aoc-GATGAAFSYP-amide [Exact Mass calculated: 1323.6,
found: 1324.5 (M+H)+].
Identification of lead quencher dye 4
The concentration of peptide 1 was adjusted using a molar excitation coefficient of 60,000
M−1 cm−1 at 430 nm. GST-tagged 14-3-3 (purified to a single band at 56 KDa on 12.5% SDS
PAGE) was dialyzed four times in 50 mM Tris pH 7.5, prior to use, and its concentration was
determined using the Bradford assay. Concentrations of each of the forty-seven assembled dyes
(See Table S1) were adjusted based on weight. PKA enzyme (2.08 mg/mL) was purchased
from Promega. 1 µM peptide 1 was incubated with 10 µM GST-tagged 14-3-3, 1 mM ATP, 2
mM DTT, 5 mM MgCl2 and 50 mM Tris-HCl at pH 7.5, in a quartz 96 well plate (Hellma).
Each dye was added to a separate well at 5 µM. 10 nM PKA was added per well and enzyme-
dependent increase in fluorescence (λex 420 nm, λem 475 nm) was determined with a plate
reader (Molecular Devices Spectra Max Gemini EM). Dyes D1, D6, D18, D33 and D39 showed
>2 fold enhancements in fluorescence.
Phosphorylation of Sensor 1 and dephosphorylation of phospho-sensor peptide
PKA-catalyzed phosphorylation of sensor 1 was performed using the conditions in
“Optimization of enzyme-dependent fold-change” described below. The mass of the resulting
phosphorylated peptide was found to be 830.6 (M + 2H)2+, 554.1 (M + 3H)3+ (Exact Mass
calculated 1658.8). The phosphorylated lead peptide was dephosphorylated using Protein
Phosphatase 1 (NEB) in the presence of 50 mM HEPES pH 7.5, 100 mM NaCl, 2 mM DTT,
0.01 % Brij 35, and 1 mM MnCl2. The mass of the resulting dephosphorylated peptide was
found to be 789.5 (M + 2H)2+ (Exact Mass calculated 1577.8).
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Acquisition of apparent Km and Vmax values
Phosphorylation-dependent increase in coumarin fluorescence intensity of peptides 1 – 3 was
monitored on a Photon Technology QM-1 spectrofluorimeter at 30 °C. Standard curves were
used to correlate fluorescence intensity with concentration of product formed. For generating
the standard curve, various substrate concentrations were incubated, in duplicate, with 5 nM
PKA at 25 °C over 30 h (in the presence of 320 µM dye, 20 µM 14-3-3τ, 1 mM ATP, 5 mM
MgCl2, 2 mM DTT and 50 mM Tris HCl pH 7.5). The fluorescence intensity after complete
phosphorylation was plotted against concentration, and parameters obtained from a linear
regression of the data were used to convert the fluorescence intensity to product concentration.
For determining the initial velocities, different concentrations of the peptide substrate was
equilibrated with 20 µM 14-3-3τ, 1 mM ATP, 5 mM MgCl2, 2 mM DTT, in 50 mM Tris buffer
pH 7.5, for 10 min. PKA (5 nM) was added and the reaction progress curves obtained. Reaction
rates were determined from the slope under conditions where 5 – 8% substrate had been
converted to product in duplicate (typically from 200 – 300 s). The resulting slopes (initial
velocity, vo) for each of the progress curves were plotted versus the concentration of substrate.
A nonlinear regression analysis (SigmaPlot version 8.02 software) was used to fit the data to
the rectangular hyperbola model.
Optimization of enzyme-dependent fold-change
1 µM peptide 1 was incubated with 1 mM ATP, 2 mM DTT, 5 mM MgCl2, 50 mM Tris-HCl
at pH 7.5, in different wells of a quartz 96-well plate. To each well, systematically varied
concentrations of dye 4 (0 – 600 µM) and GST-tagged 14-3-3 (0 – 40 µM) were added followed
by 10 nM PKA. Enzyme dependent enhancement in fluorescence (λex 420 nm, λem 475 nm)
was determined with a plate reader (Molecular Devices Spectra Max Gemini EM). The
maximum fluorescence increase was observed with 320 µM dye 4 and 20 µM GST-tagged
14-3-3τ. These optimized conditions were used to assay peptides 1 – 3 using a Photon
Technology QM-4 spectrofluorimeter. The enzyme dependent fold changes obtained under
these conditions are reported in Table 1 and are shown in Figure 2.
Acquisition of apparent Kd values for 4 with peptides 1 and 6 – 12
Varying concentrations of 4 ranging from 0.02 – 200 µM, were added to 1 µM of the coumarin-
labeled peptides in 100 mM Tris HCl pH 7.5 buffer. Fluorescence data (λex 420 nm, λem 475
nm) was acquired using a Photon Technology QM-4 spectrofluorimeter at 30 °C. Correction
for the inner filter effect was made as previously reported.36 Molar absorbtivities (λex 420 nm,
λem 475 nm) were calculated from single absorbance spectra at a [4] = 16 µM. After correcting
for the inner filter effect, the percentage of quench was plotted against the concentration of the
dye. Concentration of the dye-peptide complex was determined based on the change in
fluorescence emission intensity. The data was fit using the non-linear regression mode of
SigmaPlot ver.8.02. The calculated Kd values are reported in Table 2.
Job plot for determination of stoichiometry
Fluorescence emission (λex 420 nm, λem 475 nm) of varying concentrations of peptide 1 (0.2
µM, 0.6 µM, 1.0 µM, 1.4 µM, 1.8 µM) and dye 4 (65% purity) (1.8 µM, 1.4 µM, 1 µM, 0.6
µM, 0.2 µM) at a fixed total concentration of 2 µM was acquired in duplicate, on a Photon
Technology QM-4 spectrofluorimeter at 30 °C (Figure 3).
Mitochondria-based experiments
A standard curve for PKA concentration versus activity was generated using 1 µM peptide 1,
32 µM dye 4, 10 µM 14-3-3τ, 1 mM ATP, 5 mM MgCl2, 2 mM DTT, 1 mM cAMP, in 50 mM
Tris HCl at pH 7.5. Assays were conducted in duplicate at two concentrations of total
mitochondria protein (14 µg and 55 µg) using intact mitochondria (MitoSciences), trypsin-
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treated mitochondria (mitochondria samples incubated with 1:50 trypsin:total mitochondrial
protein for 1 h at 37° C, followed by treatment with 20-fold excess of soybean trypsin inhibitor)
and sonicated mitochondria, [mitochondria sonicated (Ultrasonic Processor, Tekmar,
Cincinnati, OH, USA) for 30 s on ice]. Initial rates were converted into pg of active PKA per
µg of mitochondria using the standard curve. Rates in the presence of Ser/Thr Phosphatase
inhibitor cocktail (P2850 Sigma) were acquired at the recommended 1:100 dilution.
Trypsin treatment of mitochondria
Mitochondria were incubated with trypsin (1:50 trypsin:total mitochondrial protein) for 1 h at
37° C followed by treatment with a 20-fold excess of soybean trypsin inhibitor. The outcome
of the trypsin digestion was validated by Western blot using an outer membrane marker, Tom
20, and a matrix marker, Hsp60.
Western blot analyses
20 µg of total protein was loaded onto 4 – 12% bis-tris polyacrylamide gels, separated by
electrophoresis, and electroblotted onto PVDF membranes. The membranes were then blocked
in 0.5% nonfat dry milk followed by incubation with the appropriate primary antibody (C
subunit of PKA 1:1000, Tom 20 1:1000, and Hsp60 1:5000) for 10 min. The membranes were
then washed 3 times with 0.1% Tween-20 in PBS followed by incubation with a goat anti-
mouse secondary antibody conjugated to horseradish peroxidase (1:2000) for 10 min. The
membranes were washed with 0.1% Tween-20 in PBS (3×), PBS (3×), and 0.5% NaCl (3×)
and detection of horseradish peroxidase performed using the ECL Plus reagent (GE).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structures of the coumarin derivatives 1 – 3 of the general form fluorophore-Aoc-
GRTGRRFSYP-amide. The fluorescent quencher Acid Green 27 (4) was identified from a
library of forty-seven dyes (Table S1).
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Fluorescence change as a function of incubation time of the PKA-catalyzed phosphorylation
of sensors (A) 1, (B) 2, (C) 3, and (D) a nonphosphorylatable Ala-for-Ser control peptide 5
(coumarin-Aoc-GRTGRRFAYP-amide). Experiments were conducted in the presence of
fluorescent quencher (4) and 14-3-3 domain. See “Optimization of enzyme-dependent fold-
change” in the Material and Methods section for experimental details.
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Fluorescence change as a function of mole fraction of sensor 1. See “Job plot for determination
of stoichiometry” in the Material and Methods section for experimental details.
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Reaction rate (nM of phosphopeptide formation/min) as a function of PKA concentration (pM).
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Strategy for assessing PKA activity on the outer membrane (blue), in the intermembrane space
(red) and in the matrix (yellow). PKA activity of intact mitochondria (A) is due to enzyme
present on the outer membrane and in the intermembrane space. Trypsinized (i) mitochondria
(B) lack outer membrane proteins and thus only intermembrane space PKA is present.
Sonicated (ii) mitochondria (C) furnishes enzyme from all three compartments and thus
represents total mitochondrial PKA.
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Assessment of mitochondrial purity and extent of trypsinolysis by Western blot analysis. (A)
The mitochondrial preparation was examined for the presence of ER (calnexin), plasma
membrane (Na+/K+-ATPase), and cytoplasmic (glyceraldehyde phosphate dehydrogenase)
proteins. A minimal amount of cytoplasmic contamination is observed. (B) Trypsin digestion
of intact mitochondria. Untreated mitochondria (lane 1) and mitochondria treated with trypsin
for 1 h at 37 °C (lane 2) were analyzed by Western blot for Hsp 60 and Tom 20, matrix and
outer membrane markers, respectively, and the PKA catalytic subunit. Complete loss of Tom
20 upon trypsin exposure implies extensive trypsinolysis of the outer membrane surface.
Complete retention of Hsp 60 implies that the mitochondrial matrix is preserved upon exposure
to trypsin.
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Protein kinase-catalyzed phosphorylation of a fluorescently quenched peptide generates a
fluorescent response in the presence of the phosphoSer-binding 14-3-3 domain.
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Table 1
Photophysical properties, fluorescent fold increase, Km, and Vmax for the PKA-catalyzed phosphorylation of
sensors 1 – 3 (where sensor = Fluorophore-Aoc-GRTGRRFSYP-amide). Kinetic properties were acquired in the
presence of quencher 4 and the 14-3-3 domain. See “Acquisition of apparent Km and Vmax values” in the Material









1 (420/475 nm) 152 2.2 ± 0.1 0.53 ± 0.03
2 (437/477 nm) 150 1.9 ± 0.1 0.34 ± 0.04
3 (450/490 nm) 28 6.2 ± 0.1 0.20 ± 0.09
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Table 2
KD values of sensor 1, and various Ala-for-Arg analogs (6 – 12) of sensor 1, with the fluorescent quencher 4.
See “Acquisition of apparent Kd values for 4 with peptides 1 and 6 – 12” in the Material and Methods section
for experimental details.
Peptide Peptide Sequence KD (µM)
1 Cou-Aoc-GRTGRRFSYP-amide 0.04 ± 0.07
6 Cou-Aoc-GATGRRFSYP-amide 1.6 ± 0.3
7 Cou-Aoc-GRTGARFSYP-amide 2.7 ± 0.6
8 Cou-Aoc-GRTGRAFSYP-amide 1.8 ± 0.2
9 Cou-Aoc-GATGRAFSYP-amide 130 ± 80
10 Cou-Aoc-GATGARFSYP-amide 130 ± 65
11 Cou-Aoc-GRTGAAFSYP-amide 130 ± 70
12 Cou-Aoc-GATGAAFSYP-amide > 200
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